NCT06431776Phase 3Recruiting

Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).

Study sponsor: Savara Inc. · SVRA

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2027-06Estimated
Enrollment · participants5Estimated
Source updated2026-02-19Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 2 fields changed

Primary completion date changed

− Before

Jan 2027

+ After

Jun 2027

Recruitment status changed

− Before

Not yet recruiting

+ After

Recruiting

Check registry source